Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
DOI:
https://doi.org/10.5210/ojphi.v6i1.5143Abstract
Data from large patient samples evaluating the magnitude of benefit with the newer anti-fungal agents are lacking. We have analyzed the Nationwide Inpt Sample (NIS) database to evaluate the trends in the incidence of fungal infections and to evaluate the potential impact of newer anti-fungal agents on in-hospital mortality among allo-SCT recipients. Our data suggests that the use of newer anti-fungal agents has an impact on the survivability of fungal infections in the setting of allo-SCT.Downloads
Published
2014-03-09
How to Cite
Shah, N., Nooka, A. K., Lonial, S., Khoury, H. J., Waller, E., & Langston, A. (2014). Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents. Online Journal of Public Health Informatics, 6(1). https://doi.org/10.5210/ojphi.v6i1.5143
Issue
Section
Poster Presentations